Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1).
Tomoki KimuraYasushi NagataHideyuki HaradaShinya HayashiYukinori MatsuoTsuyoshi TakanakaMasaki KokuboKenji TakayamaHiroshi OnishiKoichi HirakawaYoshiyuki ShioyamaTakeshi EharaPublished in: International journal of clinical oncology (2017)
The RD of SBRT for centrally located stage IA NSCLC was 60 Gy in eight fractions.